Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Wejdan M. Arif"'
Autor:
Wejdan M. Arif
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
Study purposeTo assess the prevalence of burnout among radiographers, and whether demographic variables and work-related factors had any influence on burnout and perceived stress among them.MethodsA cross-sectional quantitative survey design is adopt
Externí odkaz:
https://doaj.org/article/3cccec19cc1d4235915a3b4c2fed1a91
Autor:
Wejdan M. Arif, Philip H. Elsinga, Roel J.H.M. Steenbakkers, Walter Noordzij, Lara Barazzuol, Kelvin N.G. Wei Siang, Charlotte L. Brouwer, Bruno Lima Giacobbo, Rudi A.J.O. Dierckx, Ronald J.H. Borra, Gert Luurtsema
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 42, Iss , Pp 100652- (2023)
Background and purpose: Previous pre-clinical research using [18F]FDG-PET has shown that whole-brain photon-based radiotherapy can affect brain glucose metabolism. This study, aimed to investigate how these findings translate into regional changes in
Externí odkaz:
https://doaj.org/article/231ee542b3c5494ea02c6f0ddaab3c08
Autor:
Tetsuro Tago, Jun Toyohara, Rudi Dierckx, Norihiro Harada, Philip H. Elsinga, Hideo Tsukada, David Vállez García, Aren van Waarde, Ronald Boellaard, Lara García-Varela, Hiroyuki Ohba, Wejdan M. Arif, Takeharu Kakiuchi, Nicola Antonio Colabufo, Gert Luurtsema
Publikováno v:
García-Varela, L, Arif, W M, Vállez García, D, Kakiuchi, T, Ohba, H, Harada, N, Tago, T, Elsinga, P H, Tsukada, H, Colabufo, N A, Dierckx, R A J O, van Waarde, A, Toyohara, J, Boellaard, R & Luurtsema, G 2020, ' Pharmacokinetic Modeling of [18F]MC225 for Quantification of the P-Glycoprotein Function at the Blood-Brain Barrier in Non-Human Primates with PET ', Molecular Pharmaceutics, vol. 17, no. 9, pp. 3477-3486 . https://doi.org/10.1021/acs.molpharmaceut.0c00514
Molecular Pharmaceutics, 17(9), 3477-3486. American Chemical Society
Molecular pharmaceutics, 17(9), 3477-3486. AMER CHEMICAL SOC INC
Molecular Pharmaceutics
Molecular Pharmaceutics, 17(9), 3477-3486. American Chemical Society
Molecular pharmaceutics, 17(9), 3477-3486. AMER CHEMICAL SOC INC
Molecular Pharmaceutics
[18F]MC225 has been developed as a weak substrate of P-glycoprotein (P-gp) aimed to measure changes in the P-gp function at the blood-brain barrier with positron emission tomography. This study evaluates [18F]MC225 kinetics in non-human primates and
Autor:
Antoon T. M. Willemsen, Lara Garcia Varela, Pascalle Mossel, Rudi Dierckx, Jun Toyohara, Anna L. Bartels, Adriaan A. Lammertsma, Peter Paul De Deyn, Ronald Boellaard, Chris W.J. van der Weijden, Ronald Borra, Wejdan M. Arif, Philip H. Elsinga, Gert Luurtsema, Nicola Antonio Colabufo, Hendrikus H. Boersma
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging, 48(12), 4105-4106. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 48(12), 3886-3902. SPRINGER
Mossel, P, Garcia Varela, L, Arif, W M, van der Weijden, C W J, Boersma, H H, Willemsen, A T M, Boellaard, R, Elsinga, P H, Borra, R J H, Colabufo, N A, Toyohara, J, de Deyn, P P, Dierckx, R A J O, Lammertsma, A A, Bartels, A L & Luurtsema, G 2021, ' Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 12, pp. 4105-4106 . https://doi.org/10.1007/s00259-021-05419-8
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 48(12), 3886-3902. SPRINGER
Mossel, P, Garcia Varela, L, Arif, W M, van der Weijden, C W J, Boersma, H H, Willemsen, A T M, Boellaard, R, Elsinga, P H, Borra, R J H, Colabufo, N A, Toyohara, J, de Deyn, P P, Dierckx, R A J O, Lammertsma, A A, Bartels, A L & Luurtsema, G 2021, ' Evaluation of P-glycoprotein function at the blood–brain barrier using [18F]MC225-PET ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 48, no. 12, pp. 4105-4106 . https://doi.org/10.1007/s00259-021-05419-8
European Journal of Nuclear Medicine and Molecular Imaging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa20474e33ffa08d0d8f956ecd08154b
https://research.vumc.nl/en/publications/103373ba-a71f-4630-aab7-bcf820af9168
https://research.vumc.nl/en/publications/103373ba-a71f-4630-aab7-bcf820af9168
Autor:
Gert Luurtsema, Raaúl Martínez-Fernández, Rudi Dierckx, Ronald Borra, Michel Versluis, Carmen Gasca-Salas, Wejdan M. Arif, Philip H. Elsinga
Publikováno v:
Journal of controlled release, 324, 303-316. Elsevier
Focused ultrasound (FUS) is a minimally-invasive technology used for treatment of many diseases, including diseases related to the colon, uterus, prostate, and brain. Although it has been mainly used for ablative procedures, the ability of FUS to ope